Treatment Challenges in Acute Myeloid Leukemia in Lower-Middle-Income Countries: Navigating Intensity, Affordability, and Infections
Introduction: Acute Myeloid Leukemia (AML) is a highly aggressive and genetically heterogeneous hematologic malignancy with a potentially fatal outcome if left untreated. The standard treatment, the 7+3 regimen, involving intensive chemotherapy, has been the cornerstone of therapy for decades. Howev...
Gespeichert in:
Veröffentlicht in: | Blood 2023-11, Vol.142 (Supplement 1), p.5180-5180 |
---|---|
Hauptverfasser: | , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!